Skip to main content
Log in

Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Abstract

The protease inhibitor (PI) ritonavir is a potent inhibitor of cytochrome P450 (CYP) 3A4 activity and frequently prescribed to boost the effectiveness of other PIs as part of highly active antiretroviral therapy. It is well established that ritonavir is capable of inducing iatrogenic Cushing syndrome (ICS) through a drug–drug interaction with inhaled fluticasone that leads to the inhibition of CYP3A activity. A rapidly increasing number of case reports are being published describing ICS induced by the interaction of ritonavir and injected corticosteroids, namely triamcinolone acetonide. A review of the current literature identified 15 cases (including the one reported here) of ICS and suppression of the hypothalamic–pituitary–adrenal axis after periradicular injection of triamcinolone acetonide. Considering an aging human immunodeficiency virus (HIV)-infected population an increasing number of patients will present with degenerative musculoskeletal disease and be seeking pain relief. Based on data reported in the literature and our own experience triamcinolone injections during ritonavir-based therapy should be avoided. After failure of all conservative therapeutic options methylprednisolone may represent a therapeutic alternative for steroid injections in HIV patients receiving PI-based antiviral therapy since it has to date not been associated with ICS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Kim JH, Psevdos G, Gonzalez E, Singh S, Kilayko MC, Sharp V. All-cause mortality in hospitalized HIV-infected patients at an acute tertiary care hospital with a comprehensive outpatient HIV care program in New York City in the era of highly active antiretroviral therapy (HAART). Infection. 2013;41:545–51.

    Article  PubMed  CAS  Google Scholar 

  2. Ramanathan R, Pau AK, Busse KH, Zemskova M, Nieman L, Kwan R, Hammer JH, Mican JM, Maldarelli F. Iatrogenic Cushing syndrome after epidural triamcinolone injections in an HIV type 1-infected patient receiving therapy with ritonavir–lopinavir. Clin Infect Dis. 2008;47:97–9.

    Article  Google Scholar 

  3. Yombi JC, Maiter D, Belkhir L, Nzeusseu A, Vandercam B. Iatrogenic Cushing’s syndrome and secondary adrenal insufficiency after a single intra-articular administration of triamcinolone acetonide in HIV-infected patients treated with ritonavir. Clin Rheumatol. 2008;27[Suppl 2]:S79–82.

    Article  PubMed  Google Scholar 

  4. Dort K, Padia S, Wispelwey B, Moore CC. Adrenal suppression due to an interaction between ritonavir and injected triamcinolone: a case report. AIDS Res Ther. 2009;6:10.

    Article  PubMed  Google Scholar 

  5. Danaher PJ, Salsbury TL, Delmar JA. Metabolic derangement after injection of triamcinolone into the hip of an HIV-infected patient receiving ritonavir. Orthopedics. 2009;32:450.

    Article  PubMed  Google Scholar 

  6. Grierson MJ, Harrast MA. Iatrogenic Cushing syndrome after epidural steroid injections for lumbar radiculopathy in an HIV-infected patient treated with ritonavir: a case report highlighting drug interactions for spine interventionalists. PM R. 2012;4:234–7.

    Article  PubMed  Google Scholar 

  7. Levine D, Ananthakrishnan S, Garg A. Iatrogenic Cushing syndrome after a single intramuscular corticosteroid injection and concomitant protease inhibitor therapy. J Am Acad Dermatol. 2011;65:877–8.

    Article  PubMed  Google Scholar 

  8. Albert NE, Kazi S, Santoro J, Dougherty R. Ritonavir and epidural triamcinolone as a cause of iatrogenic Cushing’s syndrome. Am J Med Sci. 2012;344:72–4.

    Article  PubMed  Google Scholar 

  9. Maviki M, Cowley P, Marmery H. Injecting epidural and intra-articular triamcinolone in HIV-positive patients on ritonavir: beware of iatrogenic Cushing’s syndrome. Skeletal Radiol. 2013;42:313–5.

    Article  PubMed  CAS  Google Scholar 

  10. Fessler D, Beach J, Keel J, Stead W. Iatrogenic hypercortisolism complicating triamcinolone acetonide injections in patients with HIV on ritonavir-boosted protease inhibitors. Pain Physician. 2012;15:489–93.

    PubMed  Google Scholar 

  11. Hirsch HH, Battegay M. Lipodystrophy syndrome by HAART in HIV-infected patients: manifestation, mechanisms and management. Infection. 2002;30:293–8.

    Article  PubMed  CAS  Google Scholar 

  12. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Growth of spinal interventional pain management techniques: analysis of utilization trends and medicare expenditures 2000 to 2008. Spine. 2013;38:157–68.

    Article  PubMed  Google Scholar 

  13. GlaxoSmithKline. GlaxoSmithKline (GSK) clinical study register. Available at: http://www.gsk-clinicalstudyregister.com.

  14. Villikka K, Varis T, Backman JT, Neuvonen PJ, Kivistö KT. Effect of methylprednisolone on CYP3A4-mediated drug metabolism in vivo. Eur J Clin Pharmacol. 2001;57:457–60.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

JKR has received honoraria for educational activities/consulting from Abbott, Abbvie, BI, Bionor, BMS, Gilead, Janssen, Merck, Tibotec, and ViiV. All other authors have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. K. Rockstroh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarze-Zander, C., Klingmüller, D., Klümper, J. et al. Triamcinolone and ritonavir leading to drug-induced Cushing syndrome and adrenal suppression: description of a new case and review of the literature. Infection 41, 1183–1187 (2013). https://doi.org/10.1007/s15010-013-0506-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-013-0506-z

Keywords

Navigation